Picture of BioSyntech logo

BSYI BioSyntech Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for BioSyntech, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2005
March 31st
2006
March 31st
2007
March 31st
C2008
March 31st
2009
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.14-6.86-8.11-9.27-12.9
Depreciation
Amortisation
Non-Cash Items0.8271.180.5240.4313.14
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.058-0.871-0.340.072-0.129
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-3.88-6.18-7.53-8.38-9.57
Capital Expenditures-0.317-0.259-0.349-0.12-0.233
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1-6.25-1.647.890
Change in Net Investments
Cash from Investing Activities0.685-6.51-1.997.77-0.233
Financing Cash Flow Items-0.256-0.662-1.07-0.017-1.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.2916.48.91-0.58510.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.9193.74-0.599-1.20.967

Or unlock with your email

Or unlock with your email